A phase 1, open-label dose-escalation study of SEA-CD40 in adult patients with advancedmalignancies

Project: Research project

Project Details

Description

A phase 1, open-label dose-escalation study of SEA-CD40 in adult patients with advanced malignancies
StatusActive
Effective start/end date3/1/172/28/21

Funding

  • Seattle Genetics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.